Advisory Board and Editors Virology
Dongliang Liu
Dr. Dongliang Liu is a Postdoctoral Associate in the Department of Surgery at the Baylor College of Medicine. His research interests include: Cancer therapy, especially for pancreatic cancer immunotherapy; Chimeric virus-like particles (VLP) vaccine, especially for cancer vaccines; Novel antibiotics development including antimicrobial peptides; Epitomics and multi-epitope peptide vaccine development for pathogenic viruses.
Corinne F Maurice
CIFAR Azrieli Global Scholar and Tier 2 Canada Research Chair in Gut Microbial Physiology in the Department of Microbiology and Immunology at McGill University. Board member of the Microbiome and Disease Tolerance Centre.
Research in our lab aims to address two major goals:
* Identify and characterize the metabolically active microbial members of the gut microbiota.
* Determine the role of bacteriophages as regulators of the active gut microbiota.
Carla N Mavian
My research aims at understanding the eco-evolutionary pathways that lead to emergence and dispersal of zoonotic and human pathogens, with emphasis on land use and climate change, within the One Health approach. I employ genomics, metagenomics and phylodynamics as tools to elucidate the evolutionary processes and population dynamics that shape viral genetic diversity both at the inter-host (epidemics) and in intra-host level (individual infections).
Edward Mocarski
Professor Emeritus, Stanford University (2006) and Emory University (2021). Formerly, Robert W. Woodruff Professor of Microbiology and Immunology in the Emory Vaccine Center at Emory University (2006-2021) and Professor and Chair of Microbiology & Immunology at Stanford University (1983 - 2006). Previously (2009 and 2010), Distinguished Fellow at MedImmune, LLC, a wholly owned subsidiary of AstraZeneca.
Karen L. Mossman
Professor of Pathology and Molecular Medicine and member of the Institute of Infectious Disease Research and McMaster Immunology Research Centre at McMaster University. Associate Editor of PLOS Pathogens and PLOS ONE and Editorial Board Member of Journal of Virology. Recipient of the 2006 Christina Fleischmann Award from the International Society for Interferon and Cytokine Research.
Felipe G Naveca
I am a microbiologist with experience in classical and molecular techniques applied to the study of human pathogens, mainly threatening RNA and DNA viruses. My research focuses on developing diagnostic tools, molecular epidemiology, and evolution, mostly on emergent and reemergent viruses. My team approaches include genomics and phylogenetic studies to characterize known and unknown viruses; field studies on arboviral emergence in a rural area in the Brazilian Amazon; immunogenetics studies related to susceptibility or resistance against microbial infections; studies on biomarkers of acute viral illness; in vitro & in vivo virus-host interactions and evolution; and SARS-CoV-2 and other respiratory viruses molecular epidemiology. Senior investigator of Fiocruz Amazonas and Deputy Director of Research and Innovation. Member of the Brazilian Society for virology since 1997. Member of the Brazilian network of specialists in Zika and correlated diseases.
Giuseppe Parrella
Dr. Giuseppe Parrella is a Senior Researcher at the Institute for Sustainable Plant Protection of CNR, Italy.
Dr. Parrella's primary areas of expertise include plant virology, specifically with particular reference to bio-molecular characterization, diagnostics and epidemiology. He also considers Phytoplasmas and viroids among his study interests.
Dr. Parrella's current research topics include the study of the biological-molecular variability of the main viruses of horticultural, ornamental and aromatic crops; the development and validation of sensitive and highly specific diagnostic methods for the rapid diagnosis of viruses, with particular reference to emerging or recently introduced viruses and spread throughout the national territory (RT-PCR, cold probes, LAMP, real time RT-PCR, etc. .). Other interests of Dr. Parrella concern the research and characterization of sources of resistance to viruses in wild or cultivated germplasm; the use of beneficial microorganisms and their metabolites in the control of viroses; the identification and characterization of mitochondrial variants of Bemisia tabaci and of the associated geminiviruses and endosymbionts; the study of the impact of phytoviruses on human health.
George N. Pavlakis
MD, University of Athens, Greece
PhD, Syracuse University, NY
Chief of the Human Retrovirus Section of the National Cancer Institute, USA
Interests: HIV pathogenesis, Molecular Biology, gene regulation, Biotechnology, protein engineering, cytokines, Immunotherapy, Vaccines, Nucleic acid vaccines, gene therapy
Brett E Pickett
Dr. Brett Pickett is an Assistant Professor in the Microbiology and Molecular Biology Department at Brigham Young University. He completed his B.S degree in Microbiology from BYU in 2005, his Ph.D. training in Microbiology at the University of Alabama at Birmingham, and his postdoctoral training in Pathology at the University of Texas Southwestern Medical Center at Dallas. He then obtained additional experience in industry, and at the J. Craig Venter Institute, where he led investigative studies in viral comparative genomics and the human transcriptional response during viral infection. His research develops data mining methods, applies machine learning techniques, and use advanced statistical workflows to better understand how human cells respond during infection.
Wenbao Qi
Director of Department of Animal Infectious Diseases, College of Veterinary Medicine,South China Agricultural University(SCAU),Guangzhou,China.
Associated Director of National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, Guangzhou, China.
Focusing on animal influenza viruses and Japanese Encephalitis Viruses(JEV), include (1) The molecular basis of the host range and virulence of influenza viruses, (2) New vaccines of avian influenza viruses(AIV), (3) The evolution of AIVs, (4) Virus protein(AIV,JEV) and host interaction.
Priya Ramesh Prabhu
Priya Ramesh Prabhu is a Postdoctoral research fellow in the Human Biology Division at Fred Hutchinson Cancer Center, Seattle, WA. She is an immunologist with focus on Human papillomavirus (HPV) vaccination. Her expertise is in evaluation of vaccine-induced immune responses. She completed her PhD from Rajiv Gandhi Center for Biotechnology, Kerala, India, working in a Phase IV clinical trial comparing the efficacy of 2 vs 3 doses of quadrivalent HPV vaccine among Indian girls.